Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients

M H Platzer, C E H Grattan, Lars K. Poulsen, P S Skov

    53 Citations (Scopus)

    Abstract

    Endogenous histamine-releasing factors (HRFs) are involved in 30-60% of patients with chronic urticaria (CU). Evidence for their existence comes from in vivo studies of autoreactivity with the autologous serum skin test (ASST), in vitro immunoassays demonstrating autoantibodies against the immunoglobulin E (IgE) or the high affinity IgE receptor (FcepsilonRI) and serum-induced histamine release (HR) from basophils and mast cells. We have examined the correlation between the ASST and a new basophil histamine-releasing assay (the HR-Urtikaria test) in a group of well-characterized CU patients and subsequently determined the frequency of HR-Urticaria-positive sera from a larger population of CU patients.
    Original languageEnglish
    JournalAllergy: European Journal of Allergy and Clinical Immunology
    Volume60
    Issue number9
    Pages (from-to)1152-6
    Number of pages5
    ISSN0105-4538
    DOIs
    Publication statusPublished - 2005

    Keywords

    • Adolescent
    • Adult
    • Aged
    • Autoantibodies
    • Basophils
    • Child
    • Child, Preschool
    • Chronic Disease
    • Female
    • Histamine
    • Humans
    • Immunoassay
    • Infant
    • Infant, Newborn
    • Male
    • Middle Aged
    • Sensitivity and Specificity
    • Skin Tests
    • Urticaria

    Fingerprint

    Dive into the research topics of 'Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients'. Together they form a unique fingerprint.

    Cite this